Moreover, highly expressed ATB could act as a ceRNA for miR-200c and upregulate the expression of the miR-200c target genes ZEB1 and ZNF-217 to promote invasiveness and trastuzumab resistance in HER2-positive breast cancer (108). This evidence concerns the gene ERBB2 and breast carcinoma.